Akebia Therapeutics | Company Profile, Culture & Jobs

Company overview

Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease. Please review our social media guidelines at: https://akebia.com/social-media-guidelines/

Founded in 2007

Cambridge, Massachusetts, USA

273 employees (10 in marketing)

www.akebia.com

62% recommend to a friend

49% positive business outlook

People

Marketing leadership

Tammy Best

Associate Director, Marketing

At the company for 4 months

Headcount trend

Company growth over the last 12 months

Funding

Total funding

$442.5M

Last raise

$37M

Post IPO Debt, 2 years ago

Funding history

Jan 2024

Post IPO Debt Akebia Therapeutics · $37M

May 2020

Post IPO Equity Akebia Therapeutics · $151.8M

Nov 2019

Post IPO Debt Akebia Therapeutics · $100M

Apr 2015

Private Equity Round Akebia Therapeutics · $64.6M

Jun 2013

Series C Akebia Therapeutics · $41M

Audience

Monthly website visitors

9.1K

Month over month-16.1%

Quarter over quarter-17.3%

Top sourceDirect (43.2%)

Ad budget per month$0.0

Average search rank54.5

Traffic source mix

Direct

43.2%

Search

42.4%

News

Is Akebia Therapeutics Inc. stock cheap at current valuation

Nov 19, 2025 • newser.com

Tools to assess Akebia Therapeutics Inc.’s risk profile - Trade Analysis Summary & Technical Confirmation Trade Alerts

Nov 18, 2025 • newser.com

Akebia Therapeutics amends license agreement with Medice for Vafseo supply

Nov 17, 2025 • investing.com

Links

www.akebia.com

Crunchbase

X (Twitter)

Glassdoor

Akebia Therapeutics insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2007

Headquarters

Cambridge, Massachusetts

Employees

201-500

11% growth last 12mo

Marketing team

10

4% of company

14 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Late-stage · Growing 11% last 12 months · More mature

Trend

2021-06-28 -> 2025-11-24

Headcount (12 months)

+11%

Last funding round

26 months ago

Negative news (120 days)

0

Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

9.1K

Month over month-16.1%

Quarter over quarter-17.3%

Top sourceDirect (43.2%)

Traffic source mix

Direct

43.2%

Search

42.4%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

56 competitor sites

Search traffic: 2.2K organic clicks / 0 paid clicks

Organic competitors

0

Paid competitors

0

Keyword change

+101

Ad budget per month

$0.0

Average search rank

54.5

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Marketing team size

Shows saved marketing team size.

10

4% of the company • 14 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 10.

Glassdoor ratings

Shows saved Glassdoor ratings.

Glassdoor ratings

Overall rating

3.4 / 5

Work-life balance

3.7 / 5

Culture

3.4 / 5

Diversity & inclusion

3.6 / 5

Recommend to a friend

62%

Positive business outlook

49%

Funding

Shows saved funding data.

Total funding

$442.5M

Last raise

Post IPO Debt

2 years ago

Funding details

Amount raised

$442.5M

Last round

Post IPO Debt

Last fundraise

2 years ago

News

Shows saved company news.

Is Akebia Therapeutics Inc. stock cheap at current valuation

Nov 19, 2025 • newser.com

Tools to assess Akebia Therapeutics Inc.’s risk profile - Trade Analysis Summary & Technical Confirmation Trade Alerts

Nov 18, 2025 • newser.com

Akebia Therapeutics amends license agreement with Medice for Vafseo supply

Nov 17, 2025 • investing.com

Loading insights...

Headcount +11% year over year

Apr 2011

Series B Akebia Therapeutics · $22M

Social

7.3%

Referral

5.8%

Paid referral

1.1%

LinkedIn followers

Follower count and growth

Total followers

41.3K

12-mo growth

+8.1%

Monthly growth

+1.7%

Salaries

Typical salary range

$177,175 – $218,863

/ yr

Help build salary transparency at Akebia Therapeutics

Share your compensation anonymously to see full data.

Contribute

Open positions9 open marketing positions

Senior Director, Marketing New Product Planning

Akebia Therapeutics

Cambridge, MA (On-site)

$257K/yr - $317K/yrIn-houseFull-timeSenior level10+ years exp.

3 weeks ago

Director, Marketing

Akebia Therapeutics

Cambridge, MA

$214K/yr - $264K/yrIn-houseDirector/executive

5 months ago

Director, Marketing

Akebia Therapeutics

Cambridge, MA (Hybrid)

$214K/yr - $289K/yrIn-houseOtherDirector/executive

5 months ago

Associate Director, Marketing

Akebia Therapeutics

Cambridge, MA

$177K/yr - $219K/yrIn-houseManager7+ years exp.

5 months ago

Product Manager, Marketing

Akebia Therapeutics

Cambridge, MA

$110K/yr - $135K/yrIn-houseMid level3+ years exp.

5 months ago

Product Manager, Marketing

Akebia Therapeutics

Cambridge, MA (Hybrid)

$110K/yr - $148K/yrIn-houseOtherMid level3+ years exp.

5 months ago

View all 9 jobs

Akebia Therapeutics insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2007

Headquarters

Cambridge, Massachusetts

Employees

201-500

11% growth last 12mo

Marketing team

10

4% of company

14 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Late-stage · Growing 11% last 12 months · More mature

Trend

2021-06-28 -> 2025-11-24

Headcount (12 months)

+11%

Last funding round

26 months ago

Negative news (120 days)

0

Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

9.1K

Month over month-16.1%

Quarter over quarter-17.3%

Top sourceDirect (43.2%)

Traffic source mix

Direct

43.2%

Search

42.4%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

56 competitor sites

Search traffic: 2.2K organic clicks / 0 paid clicks

Organic competitors

0

Paid competitors

0

Keyword change

+101

Ad budget per month

$0.0

Average search rank

54.5

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Marketing team size

Shows saved marketing team size.

10

4% of the company • 14 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 10.

Glassdoor ratings

Shows saved Glassdoor ratings.

Glassdoor ratings

Overall rating

3.4 / 5

Work-life balance

3.7 / 5

Culture

3.4 / 5

Diversity & inclusion

3.6 / 5

Recommend to a friend

62%

Positive business outlook

49%

Funding

Shows saved funding data.

Total funding

$442.5M

Last raise

Post IPO Debt

2 years ago

Funding details

Amount raised

$442.5M

Last round

Post IPO Debt

Last fundraise

2 years ago

News

Shows saved company news.

Is Akebia Therapeutics Inc. stock cheap at current valuation

Nov 19, 2025 • newser.com

Tools to assess Akebia Therapeutics Inc.’s risk profile - Trade Analysis Summary & Technical Confirmation Trade Alerts

Nov 18, 2025 • newser.com

Akebia Therapeutics amends license agreement with Medice for Vafseo supply

Nov 17, 2025 • investing.com

Social

7.3%

Referral

5.8%

Paid referral

1.1%

Total followers

41.3K

12-mo growth

+8.1%

Monthly growth

+1.7%